FindTrial
Sign In

Piecemeal submucosal tunneling endoscopic resection for giant leiomyoma originating from the muscularis propria of esophagus: Long-term clinical outcomes

Piecemeal submucosal tunneling endoscopic resection for giant leiomyoma originating from the muscularis propria of esophagus: Long-term clinical outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059312
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-06-15
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Giant esophageal leiomyoma

Interventions

Treatment:Piecemeal submucosal tunneling endoscopic resection

Sponsors

Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Esophageal leiomyoma originating from the MP layer by EUS and/or CT; 2. Age 18-65 years old; 3. Transverse diameter >=3cm, and need to be removed in pieces; 4. No signs of malignancy or metastasis by imaging evaluation; 5. Signed consent form.

Exclusion criteria

Exclusion criteria: 1. Inability to tolerate anesthesia; 2. Abnormal blood coagulation function; 3. Pregnant women; 4. Refusal to accept P-STER.

Design outcomes

Primary

MeasureTime frame
Tumor size;Complication rate;Recurrence rate;—

Secondary

MeasureTime frame
Lesion location;Operation time;How many pieces to take out;Number of clips used;—

Countries

China

Contacts

Public ContactChaoqiang Fan

Second Affiliated Hospital of Army Medical University

fcqxhkwjs@126.com+86 15922781214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026